Compliance and manufacturer restrictions top concerns for providers
Meeting program-compliance requirements and pushing back on escalating manufacturer restrictions are the top concerns of pharmacy leaders, as uncovered during the August 2022 R1 340B Insider interactive webinar.
A full 72% of respondents cited one or the other as their primary program concern, with revenue loss largely resulting from discount restrictions ranked third.
Download the full summary report for more information on:
- Additional industry insights.
- Regulatory updates from the experts.
- Advice on how to offset savings loss.
- What to know about compliance and Health Resources and Services Administration audits.
- FAQs answered by an expert panel.
